0 CHECKOUT
Health Care Markets in China - Product Image

Health Care Markets in China

  • ID: 1408024
  • March 2016
  • Region: China
  • 257 Pages
  • AMID Co
1 of 5
China's Demand for Health Care will Continue to Grow at About 11% by 2025

China's demand for Health Care has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this READ MORE >

Note: Product cover images may vary from those shown
2 of 5

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. HEALTH CARE INDUSTRY ASSESSMENTS

Health Care Industry Structure
Market Size
Major Producer Facility Locations and Output
Market Share of Key Producers
Labor Costs
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

Overview
Medical Treatment Revenues and Forecasts by Region
Northeast
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
North
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Southeast
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Central South
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Southwest
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Northwest
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Medical Supplies Production and Demand
Major Producers
Total Output and Demand
Foreign Trade
Pricing Trends
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Pharmaceuticals Production and Demand
Major Producers
Total Output and Demand
Foreign Trade
Pricing Trends
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Medical Equipment Production and Demand
Major Producers
Total Output and Demand
Foreign Trade
Pricing Trends
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest

V. HEALTH CARE MARKET OUTLOOKS

Health Care Markets Outlook Overview
Government Health Care Regulations
Health Care Insurance Industry Overview
China’s Population Overview
Population by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Population by Age Group
Consumer Spending Trends

VI. MARKETING STRATEGIES

China Market Entry Overview
China’s Distribution System
Health Care Industry Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprise

VII. HEALTH CARE PRODUCER DIRECTORY

Medical treatment Provider Profiles
Pharmaceuticals Producer Profiles
Medical Equipment Producer Profiles
Distributors
Trading Companies
Research Institutions and Associations

2BLIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. HEALTH CARE INDUSTRY ASSESSMENTS

Major Producer Facility Locations and Output
Market Share of Key Producers
Major Distributors
Major Foreign Investments

IV. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

the Total Health Care Output and Demand
the Amount of Hospitals in Northeast
the Amount of Physicians in Northeast
the Amount of Hospital Visits in Northeast
the Medical Treatment Revenues in Northeast
the Amount of Hospitals in North
the Amount of Physicians in North
the Amount of Hospital Visits in North
the Medical Treatment Revenues in North
the Amount of Hospitals in Southeast
the Amount of Physicians in Southeast
the Amount of Hospital Visits in Southeast
the Medical Treatment Revenues in Southeast
the Amount of Hospitals in Central South
the Amount of Physicians in Central South
the Amount of Hospital Visits in Central South
the Medical Treatment Revenues in Central South
the Amount of Hospitals in Southwest
the Amount of Physicians in Southwest
the Amount of Hospital Visits in Southwest
the Medical Treatment Revenues in Southwest
the Amount of Hospitals in Northwest
the Amount of Physicians in Northwest
the Amount of Hospital Visits in Northwest
the Medical Treatment Revenues in Northwest
the Major Producers of Medical Supplies
the Total Medical Supplies Output and Demand
the Foreign Trade of Medical Supplies
the Medical Supplies Output and Demand in Northeast
the Medical Supplies Output and Demand in North
the Medical Supplies Output and Demand in Southeast
the Medical Supplies Output and Demand in Central South
the Medical Supplies Output and Demand in Southwest
the Medical Supplies Output and Demand in Northwest
the Major Producers of The Pharmaceuticals
the Pharmaceuticals Total Output and Demand
the Foreign Trade of the Pharmaceuticals
the Pharmaceuticals Output and Demand in Northeast
the Pharmaceuticals Output and Demand in North
the Pharmaceuticals Output and Demand in Southeast
the Pharmaceuticals Output and Demand in Central South
the Pharmaceuticals Output and Demand in Southwest
the Pharmaceuticals Output and Demand in Northwest
the Major Producers of Medical Equipments
the Medical Equipment Total Output and Demand
the Foreign Trade of the Medical Equipment
the Medical Equipment Output and Demand in Northeast
the Medical Equipment Output and Demand in North
the Medical Equipment Output and Demand in Southeast
the Medical Equipment Output and Demand in Central South
the Medical Equipment Output and Demand in Southwest
the Medical Equipment Output and Demand in Northwest

V. HEALTH CARE MARKET OUTLOOKS

Population in Northeast
Population in North
Population in Southeast
Population in Central South
Population in Southwest
Population in Northwest
Population by Age Group
Consumer Spending Trend

3BLIST OF CHARTS

I. INTRODUCTION

China’s Health Care Industry Output and Demand

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

IV. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

the Medical Goods Output and Demand
the Total Medical Supplies Output and Demand
the Pharmaceuticals Total Output and Demand
the Medical Equipment Total Output and Demand

V. HEALTH CARE MARKET OUTLOOKS

Health Care Industry Output by Classification
Medical Goods Demand by Classification

VI. MARKETING STRATEGIES

China’s Distribution Channel

Note: Product cover images may vary from those shown
3 of 5



Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.

Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.

Note: Product cover images may vary from those shown
4 of 5

- Huabei Pharmaceutical Group Co., Ltd.
- Shijiazhuang Pharmaceutical Group Co., Ltd.

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.